MAM
AMAG

Myriad Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Myriad Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,000
Closed -$311K – 36
2014
Q2 		$311K Sell
15,000
-35,000
-70% -$647K 0.11% 28
2014
Q1 		$968K Buy
+50,000
New +$1.06M 0.19% 35

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Myriad Asset Management's AMAG Position: Q3 2014 in Review

Myriad Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2014, closing a stake of 15,000 shares — an estimated $311K sold.

Myriad Asset Management first reported a position in AMAG in Q1 2014 and held it in 2 quarters. The position peaked at $968K in Q1 2014. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2014.

  • Myriad Asset Management reported no remaining AMAG Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Myriad Asset Management sold 15,000 AMAG Pharmaceuticals shares in Q3 2014, an estimated $311K.
  • Myriad Asset Management first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • Myriad Asset Management's AMAG Pharmaceuticals position peaked at $968K in Q1 2014.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2014.

Based on Myriad Asset Management's 13F filing for Q3 2014, filed 13 Nov 2014.